Show simple item record

dc.contributor.authorKotz, Deborah
dc.date.accessioned2020-06-30T12:05:45Z
dc.date.available2020-06-30T12:05:45Z
dc.date.issued2020-06-15
dc.identifier.urihttp://hdl.handle.net/10713/13172
dc.descriptionNews release discussing a UMB School of Medicine study to evaluate the most effective combination of antibodies against the SARS-CoV-2 virus. The research was conducted in collaboration with scientists at Regeneron Pharmaceuticals.en_US
dc.language.isoen_USen_US
dc.subjectCoronavirus Disease 2019 (COVID-19)en_US
dc.subjectRegeneron Pharmaceuticalsen_US
dc.subjectSARS-CoV-2en_US
dc.subject.lcshUniversity of Maryland, Baltimore. School of Medicineen_US
dc.subject.lcshCOVID-19 (Disease)en_US
dc.subject.meshAntibodies, Monoclonalen_US
dc.subject.meshAntibodies, Viral--therapeutic useen_US
dc.subject.meshCOVID-19en_US
dc.titleUM School of Medicine Researchers Help Identify Potent Antibody Cocktail with Potential to Treat COVID-19en_US
dc.typeArticleen_US
refterms.dateFOA2020-06-30T12:05:46Z


Files in this item

Thumbnail
Name:
SOMIdPotentAntibodyCocktailToT ...
Size:
604.5Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record